idsainfo.bsky.social - Profile | ThreadSky | a Reddit-style client for Bluesky

In adults hospitalized with critical COVID-19, should #vilobelimab compared to no vilobelimab be added to standard care? A focused update on vilobelimab is now available via #IDSAGuidelines: https://buff.ly/41C067f

submitted 1 day ago • 0 comments

Weakening our nation’s vaccine infrastructure will lead to significantly lower immunization rates and result in many more outbreaks of serious, vaccine-preventable hospitalizations and deaths. Congress must hold Secretary Kennedy accountable for these actions. (1/2)

submitted 1 day ago • 1 comment

"This will and has interrupted clinical care,” says IDSA member Rachel Bender Ignacio, MD, MPH, FIDSA. Our press briefing explores the impact of disruptions in public health information: https://buff.ly/4k1NCg5

submitted 1 day ago • 0 comments

On IDSA’s & HIVMA’s Science Speaks blog, Sonal S. Munsiff, MD, FIDSA, answers questions about an updated guideline from the American Thoracic Society, the Centers for Disease Control and Prevention, the European Respiratory Society and IDSA on treating TB in adults and children.

submitted 3 days ago • 0 comments

Your contributions to the IDSA Foundation help sustain a diverse, well-compensated ID workforce and empower ID professionals to improve patient care, advance science and promote public health. Make a contribution today: https://buff.ly/414Tug5

submitted 3 days ago • 0 comments

Join us next Wed. Feb. 26 at 4 pm ET for a webinar on careers in ID, featuring The Roadmap to Becoming an ID Physician, an interactive guide designed to support aspiring ID professionals at every stage. Register: https://buff.ly/3X4hS07

submitted 4 days ago • 0 comments

“Whether it’s spreading avian flu, HIV, Ebola or a novel pandemic virus, we as a society cannot afford to be caught with blinders on,” says HIVMA Immediate Past Chair Allison Agwu, MD, ScM, FIDSA, emphasizing the importance of federal health data. Watch our full press briefing: bit.ly/3Xa1sDv

submitted 4 days ago • 0 comments

In CID, Pattama Torvorapanit, MD, MSc, and colleagues evaluate a combination therapy of surgery, azithromycin, doxycycline, and itraconazole for vascular pythiosis and establish it as a standard treatment protocol.

submitted 4 days ago • 0 comments

You can’t hurry love but you can hurry investment in our public health preparedness workforce. ❤️ #HealthPolicyValentines

submitted 8 days ago • 1 comment

I am an ID doctor STILL standing in front of Congress, asking them to take action on antimicrobial resistance. ❤️ #HealthPolicyValentines

submitted 9 days ago • 0 comments

Hello? Is it ID you’re looking for? You can see it in versatile careers. You can see it in lives saved. It’s all you ever wanted … and the specialty’s open wide! ❤️ #HealthPolicyValentines

submitted 9 days ago • 0 comments

Near, far, wherever you are… everyone needs access to an ID doctor. ❤️ #HealthPolicyValentines

submitted 9 days ago • 0 comments

You + a career in ID = everlasting love ❤️ #HealthPolicyValentines

submitted 9 days ago • 0 comments

Don’t miss this fantastic collaboration between @jpidsociety.bsky.social and @ofidjournal.bsky.social "Healthcare Sustainability Through the Infectious Diseases Lens," exploring the critical links between infectious diseases, climate change, and sustainability. https://buff.ly/40NXQbg

submitted 10 days ago • 0 comments

The wide-ranging nature of the federal workforce cuts will leave all of us more vulnerable to disease and other safety threats, including from outside the United States, says IDSA President Tina Tan, MD, FIDSA, FPIDS, FAAP. Our statement: https://buff.ly/40UK0E8

submitted 10 days ago • 0 comments

In a joint statement, IDSA and HIVMA reaffirmed our core mission and values and emphasized that inclusion, diversity, access and equity — and an unwavering commitment to health equity — are essential to improving health outcomes for all. Read: https://buff.ly/3WXIfVA

submitted 11 days ago • 0 comments

On IDSA’s and HIVMA’s Science Speaks blog: Daniel R. Lucey, MD, MPH, FIDSA, writes about the U.S. withdrawal from WHO and the implications for smallpox virus biosecurity and biosafety.

submitted 11 days ago • 0 comments

Good decision by @idsainfo.bsky.social and its affiliated journals. It is a big responsability to do a good #peerreview! Many good journals should replicate this example. #idsky #pedsidsky academic.oup.com/idsa/pages/i...

submitted 11 days ago • 0 comments

Excited for the launch of @idsainfo.bsky.social journals peer review recognition and rewards program! We love our reviewers @cidjournal.bsky.social and are glad to be able to provide some thanks! academic.oup.com/idsa/pages/i...

submitted 12 days ago • 0 comments

In CID, Hannah Mandel, MS, and colleagues estimated long-COVID incidence among adult and pediatric populations in three nationwide research networks.

submitted 12 days ago • 0 comments

Massive cuts to funding for the National Institutes of Health will eliminate the promise of lifesaving medical treatments for millions of Americans of all ages, says IDSA President Tina Tan, MD, FIDSA, FPIDS, FAAP. Our statement: https://buff.ly/4hNBHRd

submitted 13 days ago • 0 comments

Spotlight the incredible work of your colleagues. 🌟🔦 Nominations for the 2025 IDSA and HIVMA Society Awards are now open! Submit your nomination by April 8: https://buff.ly/4aYPpOX

submitted 14 days ago • 0 comments

CDC has issued a Health Alert Network advisory about a recently confirmed outbreak of Ebola disease in Uganda caused by the Sudan virus. Read the full advisory that includes CDC’s recommendations, testing, and biosafety considerations:

submitted 17 days ago • 0 comments

Receive acknowledgement for your valuable contributions and gain access to exclusive publishing discounts when you complete three IDSA journal reviews through IDSA’s new peer reviewer recognition and rewards program! Criteria, eligibility, benefits and more: https://buff.ly/40YEtgR

submitted 18 days ago • 0 comments

New #LetsTalkID episode out! Paul Sax, MD, FIDSA, Varun Phadke, MD, and Daniel Minter, MD discuss CID's new series, "Clinical Dilemmas in Infectious Diseases," a guide through challenging clinical decisions in ID. Available where you listen to podcasts. Transcript: www.idsociety.org/multimedia/p...

submitted 22 days ago • 3 comments

The removal of #HIV- and #LGBTQ-related resources from the websites of CDC and other health agencies is deeply concerning. Access to this information is crucial for ID and HIV health care professionals. Our full statement: https://buff.ly/42AO8LI

submitted 23 days ago • 14 comments

In CID, Nicholas A Turner, MD MHSc, and colleagues describe the natural history of C. difficile NAAT+/toxin- adults.

submitted 24 days ago • 0 comments

Learn about the new ID add-on code (G0545) under Medicare that will affect your compensation by way of an additional $28.80 each time the code is used! Access our webinar recording, infographic on how to use the code (member login required) and an FAQ: https://buff.ly/40NErbz

submitted 25 days ago • 0 comments

IDSA’s & HIVMA’s Science Speaks blog revisits some of 2024’s most viewed posts and other highlights from the past year. Don’t miss the year in review.

submitted 25 days ago • 0 comments

In CID, Sarah Wondmeneh, MD, MPH, and colleagues describe the prevalence of neurologic manifestations of syphilis to better understand the burden of these potentially severe complications in the U.S.

submitted 25 days ago • 0 comments

Open Forum Infectious Diseases is seeking proposals for papers that address the unique challenges and opportunities faced by health care systems in resource-limited environments when dealing with infectious diseases. Learn more: https://buff.ly/3CdtR49

submitted 29 days ago • 0 comments

IDSA spokesperson Julio Figueroa, MD, FIDSA, emphasized the importance of coordination between human public health, animal public health and wildlife during last week’s press briefing on #avianflu. Watch our full press briefing: https://buff.ly/3C4izPC

submitted 30 days ago • 0 comments

In OFID, Isabel Rodríguez-Goncer, MD, PhD, and colleagues describe breakthrough invasive mould infections (bIMIs) that occurred in hematological patients exposed to a mould-active antifungal agent.

submitted 31 days ago • 0 comments

RSV is the leading cause of infant hospitalization in the US. The maternal RSV vaccine can prevent severe RSV disease in infants from birth up to 6 months. Protect your patients and their babies by making a strong vaccination recommendation this RSV season: https://buff.ly/3CwdX4W

submitted 32 days ago • 0 comments

⏰ TOMORROW: Join us and CDC at 4pm ET for a Clinician Call on #avianinfluenza. Health experts will share an update on the current H5N1 situation, info on testing and treatment and discuss the evolving risks of human-to-human transmission. Register: https://buff.ly/40CB476

submitted 32 days ago • 1 comment

With 2024 officially in the books, the editors-in-chief of CID, JID, and OFID wish to share a curated selection of 16 outstanding papers across all three IDSA journals. Browse the collection: https://buff.ly/40jiWxL

submitted 32 days ago • 1 comment

IDSA spokesperson Shira Doron, MD, FIDSA, says that inter-agency coordination, funding for public health and preparedness and a strong ID workforce are needed to respond to avian flu and any future outbreaks during IDSA’s latest press briefing on #avianflu. Full briefing: https://buff.ly/3C4izPC

submitted 35 days ago • 0 comments

A new Health Alert Network (HAN) Health Advisory by CDC recommends a shortened timeline for subtyping of influenza A in response to sporadic human infections with avian influenza A(H5N1) viruses amid high levels of seasonal flu activity. Read: https://bit.ly/3DZk0iY

submitted 37 days ago • 1 comment

In CID, Eleni Galanis and colleagues identify factors associated with site of infection and mortality among Cryptococcus gattii cases.

submitted 38 days ago • 0 comments

IDSA spokesperson Julio Figueroa, MD, FIDSA, of the LSU School of Medicine discusses #avianflu in Louisiana, the location of the first patient to die from avian flu. Dr. Figueroa also explains that wild birds and backyard flocks can be sources of avian flu. Full briefing: https://buff.ly/3C4izPC

submitted 39 days ago • 0 comments

Congratulations to the 8 newly designated Antimicrobial Stewardship Centers of Excellence! 🎉 Learn more: https://buff.ly/40dk3zf

submitted 39 days ago • 0 comments

In CID, Omri A Arbiv, MD, and colleagues investigate the safety of triple-dose rifampin in #tuberculosis treatment.

submitted 40 days ago • 1 comment

A victory for the ID workforce! The National Institute of Allergy and Infectious Diseases (NIAID) will be increasing interim paylines, or funding cutoff points, for research grants for fiscal year 2025. Learn more: https://buff.ly/3WieL4p

submitted 40 days ago • 0 comments

The risk to the general public from H5N1 is still very low, but poultry, dairy workers and other people who handle animals... are at higher risk and should take precautions,” says Shira Doron, MD, FIDSA, during IDSA’s latest press briefing on #avianflu developments.

submitted 43 days ago • 1 comment

In a new MedPage Today article, IDSA President Tina Tan, MD, FIDSA, FPIDS, FAAP, explains human metapneumovirus (HMPV), the respiratory illnesses that’s gaining traction in the Northern Hemisphere, including China.

submitted 44 days ago • 0 comments

Congratulations to Dan Minter, MD, the IDSA Education Community of Practice Featured Educator for the month of January! 🎉 Learn more about Dr. Minter and the other Featured Educators: bit.ly/4fR5ib3

submitted 44 days ago • 0 comments